Transformational Gift Furthers PanCAN’s Pioneering Research Initiatives to Detect and Treat Pancreatic Cancer
PanCAN has received a transformational gift of $25 million that will accelerate the organization’s pioneering research initiatives to improve detection and treatment of pancreatic cancer.
[Signal Transduction and Targeted Therapy] Investigators showed that the oncogenic BCR-ABL1 of chronic myelogenous leukemia and the cellular ABL1 tyrosine kinases phosphorylated and inactivated Smad4 to block antiproliferative TGF-β signaling.
[Science of The Total Environment] RNA interference was performed to understand the function of astakine in hematopoiesis and apoptosis in Litopenaeus vannamei under ammonia-N exposure.
[Cell Reports] The authors integrated extensive longitudinal functional assessments of HSC-specific lineage tracing with single-cell transcriptome and epitope profiling.